English
Back

Deqi Pharmaceutical (6996.HK) 2023 Annual Results Conference

Risk Disclaimer: The above content only represents the author's view. It does not represent any position or investment advice of Futu. Futu makes no representation or warranty. Read more
1
1
1
2
+0
10
See Original
Report
21K Views
Comment
Sign in to view/post comments
avatar
The official account of Antengene
As a leading biopharmaceutical company focusing on innovative anti-tumor drugs, Antengene has a vision of "doctors without borders and innovation is sustainable" and aims to provide the most cutting-edge therapies to patients in Asia-Pacific and around the world.
19KFollowers
32KVisitors
Follow